“I’m a change agent,” declared Emma Walmsley quickly after she turned chief government of GlaxoSmithKline in 2017 and, positive sufficient, the UK’s second largest pharmaceutical firm does certainly look totally different from eight years in the past.
Support Greater and Subscribe to view content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
